ZBH vs PHG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ZBH · Zimmer Biomet Holdings$105.59 ▼ 1.18%
PHG · Royal Philips$30.35 ▼ 0.52%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ZBH +20.3%
- PHG +11.7%
Head to head
| Metric | ZBH | PHG |
|---|---|---|
| Price | $105.59 | $30.35 |
| Change today | ▼ 1.18% | ▼ 0.52% |
| Market cap | $19.98B | $29.67B |
| Return, 3 months | +8.3% | +12.7% |
| Return, year to date | +18.4% | +16.5% |
| Return, 1 year | +20.6% | +12.0% |
| P/E (TTM) | 26.7 | 27.3 |
| P/B | 1.6 | 2.3 |
| P/E percentile vs own 5y | 33rd | 83rd |
| Dividend yield | 0.91% | 3.24% |
| Revenue growth (YoY, latest qtr) | +4.8% | +0.5% |
| Net profit growth (YoY) | +30.1% | +60.8% |
| Gross margin | 69.9% | 45.9% |
| Operating margin | 16.3% | 9.9% |
| Net margin | 9.5% | 6.3% |
| Return on equity | 6.4% | 10.2% |
| Analyst target vs. price | +8.4% | – |
| Analyst buy share | 27% | 0% |
| RSI (14) | 64 | 77 |
| 30-day volatility | 46.8% | 33.0% |
| Max drawdown, 1 year | -22.5% | -24.8% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PHG is the largest of the group by market value.
- ZBH has returned the most over the past year.
- ZBH carries the lowest trailing P/E.
- PHG pays the highest dividend yield.
- ZBH is growing revenue fastest.
- ZBH keeps the most profit per dollar of sales.
- PHG has been the calmest stock over the last 30 days.